BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7502498)

  • 1. The effect of granulocyte colony stimulating factor in patients with leukopenia due to sepsis.
    Bittner EW; Hartzog JM; Chendrasekhar A
    W V Med J; 1995; 91(6):273. PubMed ID: 7502498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
    Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
    Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of granulocyte colony stimulating factor, granulocyte macrophage colony stimulating factor, and tumor necrosis factor alpha during remission and infections in patients with acute leukemia.
    Duru F; Ertem U; Taçyildiz N; Kirazli S
    J Med; 1995; 26(5-6):241-52. PubMed ID: 8721901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study on acupuncture for leukopenia induced by chemotherapy].
    Han YF; Gong Z; Huang LQ; Xia X; Zhao WJ
    Zhongguo Zhen Jiu; 2010 Oct; 30(10):802-5. PubMed ID: 21058473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of granulocyte colony-stimulating factor on cardiac function in patients with acute myocardial infarction and leukopenia after revascularization.
    Guo SZ; Wang NF; Zhou L; Ye XH; Pan H; Tong GX; Yang JM; Xu J
    Chin Med J (Engl); 2010 Jul; 123(14):1827-32. PubMed ID: 20819563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte colony stimulating factor treatment for delayed recovery of ticlopidine-related neutropenia.
    Hung MJ; Wang CH; Cherng WJ
    Int J Clin Pract; 2002; 56(1):70-1. PubMed ID: 11831843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colony-stimulating factor for treatment of leukopenia after kidney allografting.
    Tajima A; Aso Y; Kawabe K; Suzuki K; Ohtawara Y; Ohta N; Hata M; Nakano M; Ushiyama T; Ueda D
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1369-70. PubMed ID: 1703338
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of granulocyte colony-stimulating factor after liver transplantation.
    Foster PF; Mital D; Sankary HN; McChesney LP; Marcon J; Koukoulis G; Kociss K; Leurgans S; Whiting JF; Williams JW
    Transplantation; 1995 Jun; 59(11):1557-63. PubMed ID: 7539958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy and granulocyte-colony stimulating factor for non-Hodgkin's lymphoma of the head and neck.
    Tsuge I; Suzuki K; Moribe K; Motai H; Kimura T; Umeda K; Kobayashi T; Yokota A; Hondo J; Baba S
    Acta Otolaryngol Suppl; 1996; 525():129-34. PubMed ID: 8908287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [G-CSF (Neupogen Roche) in the treatment of patients with chronic aplastic anemia with severe neutropenia].
    Novotný J; Zvarová M; Prazáková L; Jandlová M; Konvicková L
    Vnitr Lek; 1995 Oct; 41(10):692-5. PubMed ID: 8578701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of neutropenia in the hyper-immunoglobulin M syndrome with granulocyte colony-stimulating factor.
    Wang WC; Cordoba J; Infante AJ; Conley ME
    Am J Pediatr Hematol Oncol; 1994 May; 16(2):160-3. PubMed ID: 7513136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasculitis complicating granulocyte colony stimulating factor treatment of leukopenia and infection in Felty's syndrome.
    Farhey YD; Herman JH
    J Rheumatol; 1995 Jun; 22(6):1179-82. PubMed ID: 7545756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of recombinant human granulocyte colony stimulating factor (rhG-CSF) on leukopenia induced by chemotherapy in cancer patients].
    Shi YK; Zhou JC; Feng FY
    Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):207-10. PubMed ID: 7525173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-CSF and M-CSF: preclinical and clinical results.
    Herrmann F; Lindemann A; Mertelsmann R
    Immunol Ser; 1992; 57():651-60. PubMed ID: 1380311
    [No Abstract]   [Full Text] [Related]  

  • 18. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
    Root RK; Dale DC
    J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of granulocyte colony-stimulating factor for the treatment of severe sepsis due to melioidosis in Thailand.
    Cheng AC; Limmathurotsakul D; Chierakul W; Getchalarat N; Wuthiekanun V; Stephens DP; Day NP; White NJ; Chaowagul W; Currie BJ; Peacock SJ
    Clin Infect Dis; 2007 Aug; 45(3):308-14. PubMed ID: 17599307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Low-dose granulocyte colony-stimulating factor combined with granulocyte-macrophage colony-stimulating factor for mobilizing peripheral CD34+ hematopoietic progenitor cells].
    Meng FY; Xu B; Sun J; Yang Y; Niu JN
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep; 24(9):1051-2. PubMed ID: 15447861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.